<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is the 11th most common <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in terms of incidence </plain></SENT>
<SENT sid="1" pm="."><plain>It is most frequent in high income countries, with rates more than twice those of middle--to low-income countries </plain></SENT>
<SENT sid="2" pm="."><plain>It is usually fatal, with a 5 year survival rate of less than 35 percent </plain></SENT>
<SENT sid="3" pm="."><plain>It is not a single <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, but rather a wide group of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> (including entities such as Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>), each with a district geographical distribution, development path, age profile and prognosis </plain></SENT>
<SENT sid="4" pm="."><plain>Non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is increasing in incidence world wide </plain></SENT>
<SENT sid="5" pm="."><plain>On this background, in this paper an attempt has been made to study the trends in Non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in various Indian populations in both sexes </plain></SENT>
</text></document>